Nimble Therapeutics
Madison, US · Founded 2019 · Delaware corporation · 12 employees on LinkedIn · 1 known investors
A biopharmaceutical company that discovers and develops medicines, building on immunology research to explore additional disease areas. The page content appears to redirect to AbbVie, and provides limited specific information about Nimble Therapeutics itself.
Founders & leadership
JP
Jigar PatelExecutive
Board
DL
Investors · 1
Reported raises · per SEC filings
Form D private placements$10M disclosed across 1 round · 2019
▶$10MraisedApr 2019 · 3 investors · BiotechnologyRule 506(b)
▶$10MraisedApr 2019 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jigar PatelExecutive Officer, Director
- Rob HartDirector
- Deval LashkariDirector
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Nimble Therapeutics do?
- A biopharmaceutical company that discovers and develops medicines, building on immunology research to explore additional disease areas. The page content appears to redirect to AbbVie, and provides limited specific information about Nimble Therapeutics itself.
- Who are Nimble Therapeutics's investors?
- Nimble Therapeutics's investors include Telegraph Hill Partners.
- How much funding has Nimble Therapeutics raised?
- Nimble Therapeutics has disclosed $10M raised across 1 round.
- Where is Nimble Therapeutics headquartered?
- Nimble Therapeutics is headquartered in Madison, US.